V.A.C. ATS
Report
- Report Number
- 3009897021-2015-00003
- Event Type
- Death
- Date Received
- January 12, 2015
- Report Date
- August 1, 2014
- Manufacturer
- KCI USA INC.
- Product Code
- OMP
- PMA / PMN Number
- K062227
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
IT IS UNK WHEN THE EVENT OCCURRED AS THIS INFO HAS NOT BEEN PROVIDED. BASED ON INFO PROVIDED, IT CANNOT BE DETERMINED THAT THE INFECTION OR PT EXPIRING IS RELATED TO V.A.C. THERAPY.
EP-2 "A CASE DEVELOPED PROBABLE TOXIC SHOCK SYNDROME UNDER V.A.C. THERAPY" INCLUDED IN THE 3RD ANNUAL MEETING OF (B)(6) SOCIETY FOR SURGICAL WOUND CARE REPORTED THAT A SUSPECTED TOXIC SHOCK SYNDROME WAS OBSERVED AFTER V.A.C. THERAPY, WHICH ALLEGEDLY ENDED IN THE DEATH OF THE PT. THE PT HAD A PARAPLEGIA CAUSED BY MYELITIS TRANSVERSE 30 YEARS AGO AND HAD UNDERWENT SEVERAL SURGERIES FOR SACRAL AND ISCHIAL PRESSURE ULCERS. "AROUND (B)(6) 2010, THE PT'S SACRAL PRESSURE ULCER WORSENED. IN (B)(6), THE PT UNDERWENT A SURGICAL DEBRIDEMENT FOR SKIN NECROSIS AND AN INFECTION. V.A.C. THERAPY WAS APPLIED WHEN THE SIGNS OF INFECTION HAD RESOLVED AND GRANULATION OCCURRED. TEN DAYS AFTER THE APPLICATION OF V.A.C. THERAPY, THE PT EXPERIENCED A FEVER, DECREASED URINE VOLUME, CPK AND HIGHER SERUM CREATININE LEVELS DESPITE A SUCCESSFUL GRANULATION PROCESS. THE PT UNDERWENT A POLYMYXIN IMMUNOADSORPTION AND WAS MOVED TO THE INTENSIVE CARE UNIT. ON THE 12TH DAY, THE PT EXPIRED DUE TO MULTIORGAN FAILURE. (B)(6) WAS OBSERVED BY WOUND INCUBATION, HOWEVER, BLOOD AND THROAT CULTURES WERE NEGATIVE. THE UNIT'S SERIAL NUMBER WAS NOT PROVIDED, THEREFORE, KCI CANNOT CONDUCT A DEVICE EVALUATION OF THE UNIT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 27599 | V.A.C. ATS | OMP | KCI USA INC. | WNDATS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death |